FDA Panel Overwhelmingly Backs Approval Of Anti-Obesity Pill A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a drug which the FDA previously rejected due to safety concerns.

More From CBS Philly

Getaway Do’s And Don’ts For Hurricane Season
Five Small Midwestern Towns To Visit Now
Videos

Watch & Listen LIVE